Adaptive Biotechnologies
Price & Volume
Stats
See more52W Range | $9.95-$22.80 |
Market Cap | $3.3B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $295.4M |
Revenue Growth (YoY) | 35.1% |
Gross Profit (12 Mos) | $129.1M |
Diluted EPS | -$0.32 |
News
See moreYahoo Finance • 22 hours ago
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku
Yahoo Finance • yesterday
An Adaptive Biotechnologies Insider Sold $8.5 Million in Stock After an 85% Run
Yahoo Finance • 15 days ago
Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
Yahoo Finance • 16 days ago
BTIG Maintains a Buy Rating on Adaptive Biotechnologies (ADPT)
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 624 |